The PhD Program in Pharmacology and Experimental Therapeutics (PPET) is designed to provide scientists with the appropriate set of skills and knowledge needed to discover novel pharmacological treatments for disease, and to develop those discoveries into safe and effective therapies through molecular, cellular, whole organism, and clinical research approaches.
Mentors available for dissertation projects derive from a large variety of disciplines reflecting the broad applicability of pharmacology to basic and applied research. Current areas of interest of program members include inflammatory diseases, obesity, behavioral disorders, drug-induced hepatotoxicity, pharmacogenomics, pharmacokinetics, drug metabolism, and drug interactions. Typical research projects involve the use of in silico, molecular, cellular, animal models, as well as human subjects reflecting the bench-to-bedside approach needed to translate basic research findings into clinically useful therapeutics.
The median time to achieve the PhD degree is between 4.5 and 5 years, with graduates typically entering careers in teaching and/or research in academic, clinical, governmental, or industrial settings.
More about career options and other information related to the discipline of pharmacology please visit the web site of the American Society of Pharmacology and Experimental Therapeutics (ASPET).
PPET Program Guide